{
    "references": [
        {
            "bibentry": "Pan, ST, Li, ZL, He, ZX, et al. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol 2016; 3: 723–37.",
            "process_entry": "True",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Nikolaou, M, Pavlopoulou, A, Georgakilas, AG, Kyrodimos, E. The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis 2018; 35: 309–18. PMID: 29799080",
            "process_entry": "True",
            "doi": "10.1007/s10585-018-9903-0",
            "pmid": "29799080",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Senthebane, DA, Rowe, A, Thomford, NE, et al. The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer. Int J Mol Sci 2017; 18: E7.",
            "process_entry": "True",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Son, B, Lee, S, Youn, H, et al. The role of tumor microenvironment in therapeutic resistance. Oncotarget 2017; 8: 3933–45. PMID: 27965469",
            "process_entry": "True",
            "doi": "10.18632/oncotarget.13907",
            "pmid": "27965469",
            "pmcid": "PMC5354804",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Sowa, T, Menju, T, Chen-Yoshikawa, TF, et al. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression. Cancer Med 2017; 6: 288–97. PMID: 28028936",
            "process_entry": "True",
            "doi": "10.1002/cam4.991",
            "pmid": "28028936",
            "pmcid": "PMC5269694",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Mahoney, BP, Raghunand, N, Baggett, B, Gillies, RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol 2003; 66: 1207–18. PMID: 14505800",
            "process_entry": "True",
            "doi": "10.1016/s0006-2952(03)00467-2",
            "pmid": "14505800",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Raghunand, N, Mahoney, BP, Gillies, RJ. Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol 2003; 66: 1219–29. PMID: 14505801",
            "process_entry": "True",
            "doi": "10.1016/s0006-2952(03)00468-4",
            "pmid": "14505801",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "(a) Supuran, CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010; 20: 3467–74; (b), Supuran, CT. Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem 2018; 33: 485–95; (c), Supuran, CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7: 168–81; (d), Supuran, CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012; 27: 759–72.",
            "process_entry": "True",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "(a) McDonald, PC, Winum, JY, Supuran, CT, Dedhar, S. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 2012; 3: 84–97; (b), Supuran, CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017; 12: 61–88; (c), Supuran, CT. Structure and function of carbonic anhydrases. Biochem J 2016; 473: 2023–32; (d), Supuran, CT. Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites 2017; 7: E48.",
            "process_entry": "True",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Andreucci, E, Peppicelli, S, Carta, F, et al. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis. J Mol Med (Berl) 2017; 95: 1341–53. PMID: 28929255",
            "process_entry": "True",
            "doi": "10.1007/s00109-017-1590-9",
            "pmid": "28929255",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Ihnatko, R, Kubes, M, Takacova, M, et al. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia. Int J Oncol 2006; 29: 1025–33. PMID: 16964400",
            "process_entry": "True",
            "pmid": "16964400",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "(a) Ameis, HM, Drenckhan, A, Freytag, M, et al. Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma. J Enzyme Inhib Med Chem 2016; 31: 404–9; (b), Drenckhan, A, Freytag, M, Supuran, CT, et al. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target. J Enzyme Inhib Med Chem 2018; 33: 1024–33",
            "process_entry": "True",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "van Kuijk, SJ, Yaromina, A, Houben, R, et al. Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis. Front Oncol 2016; 6: 69. PMID: 27066453",
            "process_entry": "True",
            "doi": "10.3389/fonc.2016.00069",
            "pmid": "27066453",
            "pmcid": "PMC4810028",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "(a) Lou, Y, McDonald, PC, Oloumi, A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011; 71(9): 3364–76; (b), Pacchiano, F, Aggarwal, M, Avvaru, BS, et al. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. Chem Commun (Camb). 2010; 46: 8371–73.",
            "process_entry": "True",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Ilie, M, Mazure, NM, Hofman, V, et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer 2010; 102: 1627–35. PMID: 20461082",
            "process_entry": "True",
            "doi": "10.1038/sj.bjc.6605690",
            "pmid": "20461082",
            "pmcid": "PMC2883156",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Hussain, SA, Ganesan, R, Reynolds, G, et al. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer 2007; 96: 104–9. PMID: 17213826",
            "process_entry": "True",
            "doi": "10.1038/sj.bjc.6603530",
            "pmid": "17213826",
            "pmcid": "PMC2360224",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "(a) Dubois, L, Peeters, S, Lieuwes, NG, et al. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother Oncol 2011; 99: 424–31; (b), Supuran, CT, Alterio, V, Di Fiore, A, et al. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one. Med Res Rev 2018; 38: 1799–1836; doi: DOI: 10.1002/med.21497; (c), Borras, J, Scozzafava, A, Menabuoni, L, et al. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? Bioorg Med Chem. 1999; 7: 2397–406.",
            "process_entry": "True",
            "doi": "10.1002/med.21497; (c)",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "(a) Dubois, L, Peeters, SG, van Kuijk, SJ, et al. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother Oncol 2013; 108: 523–8; (b), Supuran, CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016; 31: 345–60; (c), Alterio, V, Di Fiore, A, D'Ambrosio, K, Supuran, CT, De Simone, G. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012; 112: 4421–68.",
            "process_entry": "True",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Vaeteewoottacharn, K, Kariya, R, Dana, P, et al. Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma. Tumour Biol 2016; 37: 9023–35. PMID: 26762407",
            "process_entry": "True",
            "doi": "10.1007/s13277-016-4785-8",
            "pmid": "26762407",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Webb, BA, Chimenti, M, Jacobson, MP, Barber, DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011; 11: 671–7. PMID: 21833026",
            "process_entry": "True",
            "doi": "10.1038/nrc3110",
            "pmid": "21833026",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Peppicelli, S, Bianchini, F, Calorini, L. Extracellular acidity, a \"reappreciated\" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer Metastasis Rev 2014; 33: 823–32. PMID: 24984804",
            "process_entry": "True",
            "doi": "10.1007/s10555-014-9506-4",
            "pmid": "24984804",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Ruzzolini, J, Peppicelli, S, Andreucci, E, et al. Everolimus selectively targets vemurafenib resistant BRAF(V600E) melanoma cells adapted to low pH. Cancer Lett 2017; 408: 43–54. PMID: 28826720",
            "process_entry": "True",
            "doi": "10.1016/j.canlet.2017.08.010",
            "pmid": "28826720",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Davey, RJ, van der Westhuizen, A, Bowden, NA. Metastatic melanoma treatment: combining old and new therapies. Crit Rev Oncol Hematol 2016; 98: 242–53. PMID: 26616525",
            "process_entry": "True",
            "doi": "10.1016/j.critrevonc.2015.11.011",
            "pmid": "26616525",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Tentori, L, Lacal, PM, Graziani, G. Challenging resistance mechanisms to therapies for metastatic melanoma. Trends Pharmacol Sci 2013; 34: 656–66. PMID: 24210882",
            "process_entry": "True",
            "doi": "10.1016/j.tips.2013.10.003",
            "pmid": "24210882",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Gogas, HJ, Kirkwood, JM, Sondak, VK. Chemotherapy for metastatic melanoma: time for a change? Cancer 2007; 109: 455–64. PMID: 17200963",
            "process_entry": "True",
            "doi": "10.1002/cncr.22427",
            "pmid": "17200963",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Quirt, I, Verma, S, Petrella, T, et al. Temozolomide for the treatment of metastatic melanoma: a systematic review. Oncologist 2007; 12: 1114–23. PMID: 17914081",
            "process_entry": "True",
            "doi": "10.1634/theoncologist.12-9-1114",
            "pmid": "17914081",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Lovitt, CJ, Shelper, TB, Avery, VM. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer 2018; 18: E41.",
            "process_entry": "True",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Davis, T, van Niekerk, G, Peres, J, et al. Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK. Biochem Pharmacol 2018; 148: 174–83. PMID: 29309757",
            "process_entry": "True",
            "doi": "10.1016/j.bcp.2018.01.012",
            "pmid": "29309757",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Wang, X, Teng, Z, Wang, H, et al. Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system. Int J Clin Exp Pathol 2014; 7: 1337–47. PMID: 24817930",
            "process_entry": "True",
            "pmid": "24817930",
            "pmcid": "PMC4014214",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Smith, L, Watson, MB, O'Kane, SL, et al. The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther 2006; 5: 2115–20. PMID: 16928833",
            "process_entry": "True",
            "doi": "10.1158/1535-7163.mct-06-0190",
            "pmid": "16928833",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "He, J, Pei, L, Jiang, H, et al. Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation. J Cancer 2017; 8: 1187–96. PMID: 28607593",
            "process_entry": "True",
            "doi": "10.7150/jca.18171",
            "pmid": "28607593",
            "pmcid": "PMC5463433",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Bracht, K, Nicholls, AM, Liu, Y, Bodmer, WF. 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency. Br J Cancer 2010; 103: 340–6. PMID: 20606684",
            "process_entry": "True",
            "doi": "10.1038/sj.bjc.6605780",
            "pmid": "20606684",
            "pmcid": "PMC2920028",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "(a) Wojtkowiak, JW, Verduzco, D, Schramm, KJ, Gillies, RJ. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm 2011; 8: 2032–8; (b), Neri, D, Supuran, CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011; 10: 767–77.",
            "process_entry": "True",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "(a) Bozdag, M, Carta, F, Ceruso, M, et al. Discovery of 4-hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 analogues for the treatment of hypoxic tumors overexpressing carbonic anhydrase IX. J Med Chem 2018; 61: 6328–38; (b), McDonald, PC, Swayampakula, M, Dedhar, S. Coordinated regulation of metabolic transporters and migration/invasion by carbonic anhydrase IX. Metabolites 2018; 8: E20; (c), Boyd, NH, Walker, K, Fried, J, et al. Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight 2017; 2: 92928.",
            "process_entry": "True",
            "xmlid": "CIT0034"
        }
    ],
    "localid": "MED-30362384",
    "doi": "10.1080/14756366.2018.1532419",
    "pmid": "10.1080/14756366.2018.1532419",
    "pmcid": "30362384",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30362384/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),118,313)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),432,403)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),836,223)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,122)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,122)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0005",
                "rp_string": "5–7",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),124,157)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),516,301)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 7,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),818,205)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0011",
                "rp_string": "11",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),818,205)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1382,438)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0012",
                "rp_string": "12–16",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),2007,267)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),2007,267)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[12]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),2275,105)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),152,350)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 14,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),1,263)",
                "containers_title": [
                    "Materials and methods",
                    "Cell cultures"
                ]
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),265,559)",
                "containers_title": [
                    "Materials and methods",
                    "Cell cultures"
                ]
            }
        ],
        [
            {
                "n_rp": 16,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p),1,121)",
                "containers_title": [
                    "Results",
                    "SLC-0111 CAIX inhibitor sensitises melanoma cells to Dacarbazine and Temozolomide treatment"
                ]
            }
        ],
        [
            {
                "n_rp": 17,
                "xref_id": "CIT0020",
                "rp_string": "20–22",
                "rp_xpath": "/article/body/sec[4]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[1]),208,155)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[4]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[1]),364,419)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 19,
                "xref_id": "CIT0023",
                "rp_string": "23–25",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),585,92)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 20,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),1,150)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),1,150)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0027",
                "rp_string": "27–30",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),77,215)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),269,197)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[4]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[5]),269,197)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 25,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[4]/p[6]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[6]),241,167)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 26,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[4]/p[6]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[6]),545,267)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[4]/p[6]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[6]),997,95)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ]
    ]
}